The considerable evidence to date indicates that well-implemented syringe exchange programs (SEPs) can be quite effective in reducing human immunodeficiency virus (HIV) transmission among injecting drug users (IDUs), [1] [2] [3] [4] [5] [6] although not all syringe exchanges have been successful in preventing epidemics of HIV among IDUs. 7 Syringe exchange has remained quite controversial in the United States, and there has not been any federal government funding of syringe exchange efforts in the country. In the absence of federal funding, a number of state and local governments have funded SEPs in their jurisdictions. We report here on trends in state and local government funding of SEPs in the United States and on the differences in programs that do and do not receive state and local government funding.
METHODS
Since 1994, staff of Beth Israel Medical Center in New York City and of the North American Syringe Exchange Network (NASEN) have conducted annual surveys of SEPs in the United States. NASEN staff contact the directors of all SEPs known to NASEN to ask if the program is willing to participate in the survey. Although there is no comprehensive listing of SEPs in the United States, membership in NASEN is free and provides a number of services to SEPs, so that we estimate 95% or more of regularly operating SEPs in the United States do belong to NASEN. Program directors who agree to participate in the survey are first sent a copy of the questionnaire and then are interviewed by Beth Israel research staff over the telephone. The interview covers operating characteristics of the programs for the calendar year prior to the survey, including sources of funding.
RESULTS
Since the start of these interviews, the response rate has been approximately 80% of SEPs known to NASEN (There were missing data from some programs in each of the surveys, so that the total number of programs for which we obtained funding data may be slightly less than the total number of programs participating in a given survey.) Foundation grants and private donations are the two other major sources of funding for SEPs in the United States. Among the programs that did receive state/local government funding, this funding source accounted for a mean of 87% (median of 100%) of the budget for syringe exchange services. (Note that many syringe exchanges are part of larger multiservice programs. The budget percentage reported here refers to syringe exchange services rather than all services provided by the programs.)
The Table shows the relationships between receiving state/local government funding and the size of the SEPs (measured in numbers of syringes exchanged per year), the mean number of additional on-site services offered by the program (on-site services and services through referrals), and whether the SEP provides voluntary HIV counseling and testing. It is clear that receiving state/local government funding is associated with larger numbers of syringes exchanged, more total services offered, and a greater likelihood of offering voluntary counseling and testing. Despite the lack of federal funding for SEPs in the United States, the proportion of programs that receive government funding (state and/or local) has remained at approximately 50% as the number of SEPs has increased from 60 SEPs participating in the 1994-1995 survey to 127 SEPs participating in the 2000 survey. The current budget problems that exist for many state and local governments, however, may lead to a reduction in public funding for SEPs. In addition, the low HIV incidence and prevalence among IDUs in many areas with SEPs may also reduce the perceived urgency of funding SEPs. (SEPs may become victims of their own success in preventing HIV infection among IDUs.) Among the SEPs that do receive state/local government funding, this funding is the predominant source of monies for their syringe exchange services, accounting for a mean of 87% of funding for the syringe exchange services. Thus, if the programs were to lose state/local government funding, it is highly unlikely that they would be able to maintain syringe exchange services at anything near present levels.
Changing laws to permit pharmacies to sell sterile injection equipment legally to drug injectors, as has been done in New York, Illinois, Rhode Island, Hawaii, and Minnesota, may be a low-cost method of increasing access to sterile injection equipment. Such new laws are likely to be desirable even if public funding of SEPs is not reduced.
State and local government funding is associated with a number of desirable characteristics of SEPs. First, it is strongly associated with the numbers of syringes exchanged by the programs. Providing sufficient numbers of sterile needles and syringes to reduce risk behavior and HIV transmission is clearly a fundamental purpose of SEPs. The Table suggests that it is unusual for an SEP to reach a very large size without government funding. Second, government funding is also strongly associated with provision of multiple services by the programs. Thus, SEPs with state and local government funding are more likely to be able to serve as part of comprehensive HIV prevention networks for IDUs. This also includes provision of voluntary HIV counseling and testing, which is central to the new Centers for Disease Control and Prevention strategy of working with HIV seropositives to reduce further HIV transmission. 8 In the absence of federal funding for SEPs in the United States, state and local governments have come to play a critical role in syringe exchange. If HIV transmission is to be reduced further among IDUs in the United States, it may be necessary to obtain federal funding for SEPs or for state and local governments to expand their already substantial roles in supporting SEPs.
